Algorithm for Evaluation of the Potential Heart Transplant Recipient - Flowchart
Algorithm for Evaluation of the Potential Heart Transplant Recipient - Flowchart Heart Failure Heart Failure
«Flowchart»

Does the patient have less than 1-yr life expectancy?


    Cardiogenic shock requiring mechanical support or highdose inotropic/pressor drugs?
    Stage D, refractory heart failure symptoms despite maximal therapy?
    Recurrent life-threatening arrhythmias despite maximal interventions and implanted defibrillator?
    Refractory angina without potential for revascularization?

Does the patient have less than 1-yr life expectancy?


    Cardiogenic shock requiring mechanical support or highdose inotropic/pressor drugs?
    Stage D, refractory heart failure symptoms despite maximal therapy?
    Recurrent life-threatening arrhythmias despite maximal interventions and implanted defibrillator?
    Refractory angina without potential for revascularization?

Does the patient have less than 1-yr life expectancy?

Does the patient have less than 1-yr life expectancy?

    Cardiogenic shock requiring mechanical support or highdose inotropic/pressor drugs?
    Stage D, refractory heart failure symptoms despite maximal therapy?
    Recurrent life-threatening arrhythmias despite maximal interventions and implanted defibrillator?
    Refractory angina without potential for revascularization?

Cardiogenic shock requiring mechanical support or highdose inotropic/pressor drugs?
Stage D, refractory heart failure symptoms despite maximal therapy?
Recurrent life-threatening arrhythmias despite maximal interventions and implanted defibrillator?
Refractory angina without potential for revascularization?

Yes

Yes

Yes

Yes

Consider permanent mechanical support

Consider permanent mechanical support

Consider permanent mechanical support

Age >65–70 (?) yr?

Age >65–70 (?) yr?

Age >65–70 (?) yr?

Yes

Yes

Yes Yes

No

No

No No

No

No

No

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

End

End

End

Consider permanent mechanical support

Consider permanent mechanical support

Consider permanent mechanical support

Active or recent malignancy?

Active or recent malignancy?

Active or recent malignancy?

Yes

Yes

Yes Yes

No

No

No No

No

No

No

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

FEV/FVC <40%?

FEV/FVC <40%?

FEV/FVC <40%?

Consider permanent mechanical support, unlikely candidate

Consider permanent mechanical support, unlikely candidate

Consider permanent mechanical support, unlikely candidate

Diabetes with severe end-organ damage?

Diabetes with severe end-organ damage?

Diabetes with severe end-organ damage?

Yes

Yes

Yes Yes

No

No

No No

No

No

No

No

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

Consider heart-lung transplantation

Consider heart-lung transplantation

Consider heart-lung transplantation

Yes

Yes

Yes Yes

No

No

No No

No

No

No

No

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

Nutritional modification

Nutritional modification

Nutritional modification

BMI <20 or BMI >35–40?

BMI <20 or BMI >35–40?

BMI <20 or BMI >35–40?

Yes

Yes

Yes Yes

No

No

No No

BMI >35–40

BMI >35–40

BMI >35–40

Consider permanent mechanical support (VAD) to weight loss

Consider permanent mechanical support (VAD) to weight loss

Consider permanent mechanical support (VAD) to weight loss

Consider heart-lung transplantation

Consider heart-lung transplantation

Consider heart-lung transplantation

Irreversible pulmonary hypertension?

Irreversible pulmonary hypertension?

Irreversible pulmonary hypertension?

Yes

Yes

Yes Yes

No

No

No No

No

No

No

No

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

End-of-life considerations or investigational therapy

Individual transplant team decisions

Individual transplant team decisions

Individual transplant team decisions

Determine transplant status and immunologic status

Determine transplant status and immunologic status

Determine transplant status and immunologic status

Other comorbidity present? (cirrhosis, vascular disease, addictions, hepatitis C, HIV, social or psychiatric disorders)

Other comorbidity present? (cirrhosis, vascular disease, addictions, hepatitis C, HIV, social or psychiatric disorders)

Other comorbidity present? (cirrhosis, vascular disease, addictions, hepatitis C, HIV, social or psychiatric disorders)

Yes

Yes

Yes Yes

No

No

No No

Acceptable

Acceptable

Acceptable

Acceptable

List for transplant

List for transplant

List for transplant